muscular dystrophy

Sarepta Sarepta Therapeutics
Favicon Fierce Biotech

Sarepta faces new scrutiny after 3rd patient death

Analysts grilled Sarepta on Friday for failing to disclose a third gene therapy patient death prior to a restructuring announcement earlier this week.
Fraiser Kansteiner Jul 18, 2025 10:19am
Duchenne muscular dystrophy

MDA and fitness clubs to raise money with national workout

Mar 30, 2023 9:15am
Title wellness health healthy food diet exercise fitness CREDIT Gettyudra

Muscular Dystrophy Association kicks off #30DaysofStrength

Sep 7, 2022 8:13am
Employment contract

Marathon makes surprise deal to sell Emflaza for $140M-plus

Mar 16, 2017 10:40am
congress

Lawmakers pull FDA into the dock over Marathon's Emflaza nod

Mar 15, 2017 4:51pm